RNA Disease Diagnostics (RNADD)

RNA Disease Diagnostics (RNADD) was formed to commercialize a best-in-class rapid and accurate molecular diagnostic technology platform that will democratize point-of-care and home-use testing. The Company plans to leverage its proprietary AntiSense RNA diagnostic platform across multiple infectious diseases and to create highly accurate, quick, affordable, and minimally invasive disease diagnostic testing kits.

United States

Product Areas


Antisense molecular diagnostics tests Show all suppliers
COViD-19 Antisense molecular diagnostic test Show all suppliers
Point-of-Need/Handheld Show all suppliers
SARS-CoV-2 Show all suppliers